空腹血糖与糖化血红蛋白的访视间变异与阿尔茨海默病风险增加相关:台湾糖尿病研究
该研究纳入16,706例年龄≥60岁、无阿尔茨海默病(AD)诊断的2型糖尿病患者,分析空腹血糖(FPG)和糖化血红蛋白(HbA1c)的访视间变异系数(CV)与AD发病的关联。中位随访8.88年,发现831例AD,FPG CV和HbA1c CV第三分位均与AD风险独立相关,风险比分别为1.27(95%CI 1.06-1.52)和1.32(95%CI 1.11-1.58)。
要点
- FPG CV第三分位与AD风险相关,HR 1.27(95%CI 1.06-1.52)。
- HbA1c CV第三分位与AD风险相关,HR 1.32(95%CI 1.11-1.58)。
- 血糖变异与AD的关联独立于HbA1c等传统风险因素。
核心结论
- FPG CV和HbA1c CV与AD独立相关。
- 血糖变异与AD的关联提示可能存在共同的病理生理机制,值得进一步研究。
- 需要进一步研究确认结果,并评估FPG CV和HbA1c CV是否可作为有风险2型糖尿病患者的治疗靶点。
研究设计与样本
- 研究纳入国家糖尿病护理管理项目中年龄≥60岁、无AD诊断的2型糖尿病患者,共16,706例。
- 采用扩展Cox比例风险回归模型分析AD发病风险,并考虑死亡竞争风险。
主要发现
- 中位随访8.88年,共发现831例AD,粗发病率为3.5/1,000人年。
- 调整社会人口学因素、生活方式、糖尿病相关变量、FPG和HbA1c、药物相关变量及合并症后,FPG CV第三分位与AD风险显著相关,HR 1.27(95%CI 1.06-1.52)。
- 调整后,HbA1c CV第三分位与AD风险显著相关,HR 1.32(95%CI 1.11-1.58)。
局限性
- 需要进一步研究确认本研究结果。
- 需要进一步研究评估FPG CV和HbA1c CV是否可作为有风险2型糖尿病患者的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The relationship between glycemic variability and the incidence of Alzheimer disease (AD) in patients with type 2 diabetes mellitus (T2DM) is unclear. The aim of this study was to examine visit-to-visit variations in fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c) represented by the coefficient of variation (CV) and to determine whether they were independently associated with AD, irrespective of HbA1c and other traditional risk factors in such patients. RESEARCH DESIGN AND METHODS: Patients with T2DM enrolled in the National Diabetes Care Management Program, age ≥60 years, and without diagnosis of AD (n = 16,706) were included in the study. Potential risk factors were analyzed using extended Cox proportional hazards regression models for competing risk of mortality on AD incidence. RESULTS: During a median follow-up of 8.88 years, 831 incident cases of AD were identified, with a crude incidence rate of 3.5/1,000 person-years. After adjustment for sociodemographic factors, lifestyle behaviors, diabetes-related variables, FPG and HbA1c, drug-related variables, and comorbidities, both FPG CV and HbA1c CV were found to be significant predictors of AD, with corresponding hazard ratios of 1.27 (95% CI 1.06-1.52) for the third tertile in FPG CV and 1.32 (95% CI 1.11-1.58) for the third tertile in HbA1c CV. CONCLUSIONS: FPG CV and HbA1c CV are independently associated with AD. The associations between glycemic variability and AD demonstrated in this study suggest a linked pathophysiological mechanism, which is worthy of further investigation. Further research is required to confirm our results and to evaluate whether FPG CV and HbA1c CV can be valuable therapeutic targets for patients with T2DM at risk.
引用
- Li TC, Yang CP, Tseng ST, et al. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA1c Associated With an Increased Risk of Alzheimer Disease: Taiwan Diabetes Study. Diabetes Care. 2017. PMID: 28705834. doi:10.2337/dc16-2238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。